Detalles de la búsqueda
1.
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
Cancer
; 129(7): 1085-1095, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642837
2.
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy.
J Natl Compr Canc Netw
; 21(5): 473-479.e4, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156482
3.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35390339
4.
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.
BMC Cancer
; 22(1): 1213, 2022 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36434554
5.
Identifying patients eligible for PARP inhibitor treatment: from NGS-based tests to 3D functional assays.
Br J Cancer
; 125(1): 7-14, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33767416
6.
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.
Eur J Nucl Med Mol Imaging
; 48(6): 1998-2008, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33221969
7.
CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
BMC Cancer
; 21(1): 1054, 2021 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34563169
8.
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Int J Cancer
; 146(6): 1643-1651, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318983
9.
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
BMC Cancer
; 19(1): 198, 2019 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30832617
10.
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.
BMC Cancer
; 18(1): 110, 2018 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-29382311
11.
Imputability of Adverse Events to Anticancer Drugs.
N Engl J Med
; 380(19): 1873-1874, 2019 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31067382
12.
Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study.
BMC Cancer
; 17(1): 355, 2017 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28532444
13.
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.
BMC Cancer
; 17(1): 549, 2017 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28814281
14.
How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study.
Support Care Cancer
; 24(3): 1131-8, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26268784
15.
Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Ther Adv Urol
; 16: 17562872241229876, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38425504
16.
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.
Mol Oncol
; 17(1): 27-36, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36370117
17.
Gemcitabine plus platinum-based chemotherapy in combination with bevacizumab for kidney metastatic collecting duct and medullary carcinomas: Results of a prospective phase II trial (BEVABEL-GETUG/AFU24).
Eur J Cancer
; 186: 83-90, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37054556
18.
[Management of adverse effects of targeted therapy toxicities in oncology]. / Principes de prise en charge des effets indésirables des thérapies ciblées en cancérologie.
Rev Prat
; 62(1): 17-25, 2012 Jan.
Artículo
en Francés
| MEDLINE | ID: mdl-22335060
19.
The promising prognostic value of vagal nerve activity at the initial management of ovarian cancer.
Front Oncol
; 12: 1049970, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36523968
20.
Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations.
Curr Oncol
; 29(4): 2776-2791, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35448200